08/22/2025
3:10 PM | Dworak Leiden (Reporting)
TScan Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/20/2025
3:10 PM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2025
6:06 AM | Lynx1 Capital Management LP (Filed by)
TScan Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
08/12/2025
8:07 AM | Adage Capital Management, L.P. (Filed by)
TScan Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
08/12/2025
6:15 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2025
6:30 AM | TScan Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/16/2025
6:02 PM | BlackRock, Inc. (Filed by)
TScan Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
07/02/2025
4:20 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2025
3:30 PM | TScan Therapeutics (Issuer)
Woods Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2025
3:32 PM | Nicholson Garry A (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2025
3:32 PM | Klencke Barbara (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for TCRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for TScan Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
07/02/2025
6:00 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2025
3:49 PM | Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2025
3:40 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
TScan Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
05/15/2025
1:19 PM | EcoR1 Capital, LLC (Filed by)
TScan Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
05/14/2025
6:01 AM | TScan Therapeutics (Filer)
| Form DEF 14A | |
05/14/2025
6:05 AM | TScan Therapeutics (Filer)
| Form DEFA14A | |
05/14/2025
6:11 AM | TScan Therapeutics (Filer)
| Form ARS | |
05/06/2025
6:15 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2025
6:30 AM | TScan Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/24/2025
8:12 AM | BlackRock, Inc. (Filed by)
TScan Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
03/16/2025
11:15 PM | TScan Therapeutics (Filer)
| Form EFFECT | |
03/05/2025
3:28 PM | TScan Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/05/2025
6:30 AM | TScan Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/05/2025
6:15 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
8:00 AM | Lynx1 Capital Management LP (Filed by)
TScan Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/12/2025
8:38 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
TScan Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/11/2025
4:47 PM | Louis Chrystal (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
4:47 PM | Amello Jason (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
4:52 PM | MacBeath Gavin (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
4:54 PM | Dworak Leiden (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
4:54 PM | TScan Therapeutics (Issuer)
ZDRAVESKI ZORAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
3:15 PM | Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
6:15 AM | TScan Therapeutics (Filer)
| Form 424B5 | |
12/26/2024
6:30 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/23/2024
6:27 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/16/2024
3:26 PM | Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
7:14 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2024
7:05 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/19/2024
3:26 PM | Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
2:05 PM | Cormorant Asset Management, LP (Filed by)
TScan Therapeutics (Subject)
| Form SC 13G/A | |
One stock to replace Nvidia (Ad) Investing Legend Hints the End May be Near for These 3 Iconic Stocks
One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast. Click to get the full details on Eric Fry's "Nvidia alternative" right here. |
11/08/2024
1:17 PM | BlackRock, Inc. (Filed by)
TScan Therapeutics (Subject)
| Form SC 13G | |
11/01/2024
6:00 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/21/2024
3:11 PM | BlackRock, Inc. (Filed by)
TScan Therapeutics (Subject)
| Form SC 13G | |
09/24/2024
4:26 PM | Klencke Barbara (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
5:46 PM | TScan Therapeutics (Issuer)
ZDRAVESKI ZORAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
5:57 PM | Klencke Barbara (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
4:50 PM | TScan Therapeutics (Subject)
ZDRAVESKI ZORAN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
MarketBeat All Access